Incyte (INCY) Earnings Date, Estimates & Call Transcripts → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free INCY Stock Alerts $53.06 -0.44 (-0.82%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 6EstimatedActual EPS (Feb. 13) $1.06 Missed By -$0.09 Consensus EPS (Feb. 13) $1.15 Read Call TranscriptListen to Call Get Incyte Earnings AlertsEnter your email address below to receive the latest news and earnings results for INCY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueINCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INCY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Incyte Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.68$0.68$0.68Q2 20241$0.83$0.83$0.83Q3 20241$0.90$0.90$0.90Q4 20241$0.90$0.90$0.90FY 20244$3.31$3.31$3.31Q1 20251$0.90$0.90$0.90Q2 20251$1.06$1.06$1.06Q3 20251$1.31$1.31$1.31Q4 20251$1.19$1.19$1.19FY 20254$4.46$4.46$4.46INCY Earnings Date and InformationIncyte last issued its quarterly earnings results on February 13th, 2024. The biopharmaceutical company reported $1.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.15 by $0.09. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. Its revenue for the quarter was up 9.3% on a year-over-year basis. Incyte has generated $3.30 earnings per share over the last year ($3.30 diluted earnings per share) and currently has a price-to-earnings ratio of 16.1. Earnings for Incyte are expected to grow by 26.84% in the coming year, from $3.54 to $4.49 per share. Incyte has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off prior year's report dates.Read More Incyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/6/2024Estimated)------- 2/13/2024Q4 2023$1.15$1.06($0.09)$0.75$1.00 billion$1.01 billion 10/31/2023Q3 2023$0.91$0.91-$1.06$973.32 million$919.03 million8/1/2023Q2 2023$0.69$0.77+$0.08$0.64$920.18 million$954.61 million5/2/2023Q1 2023$0.68$0.18($0.50)$0.26$871.17 million$808.67 million2/7/2023Q4 2022$0.5930$0.62+$0.0270$0.75$880.25 million$926.70 million 11/1/2022Q3 2022$0.54$0.44($0.10)$0.38$847.00 million$823.30 million Get the Latest News and Ratings for INCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Incyte and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022Q2 2022$0.61$0.85+$0.24$0.98$818.25 million$911.40 million 5/3/2022Q1 2022$0.34$0.40+$0.06$0.63$753.54 million$733.20 million 2/8/2022Q4 2021$0.65($0.07)($0.72)($2.68)$813.38 million$862.50 million 11/2/2021Q3 2021$0.55$1.00+$0.45$1.18$748.16 million$812.99 million8/3/2021Q2 2021$0.54$0.80+$0.26$0.63$686.95 million$705.71 million Incyte Earnings - Frequently Asked Questions When is Incyte's earnings date? Incyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on INCY's earnings history. Did Incyte beat their earnings estimates last quarter? In the previous quarter, Incyte (NASDAQ:INCY) missed the analysts' consensus estimate of $1.15 by $0.09 with a reported earnings per share (EPS) of $1.06. Learn more on analysts' earnings estimate vs. INCY's actual earnings. How can I listen to Incyte's earnings conference call? The conference call for Incyte's latest earnings report can be listened to online. Listen to Conference Call How can I read Incyte's conference call transcript? The conference call transcript for Incyte's latest earnings report can be read online. Read Transcript How much revenue does Incyte generate each year? Incyte (NASDAQ:INCY) has a recorded annual revenue of $3.70 billion. How much profit does Incyte generate each year? Incyte (NASDAQ:INCY) has a recorded net income of $597.60 million. INCY has generated $3.30 earnings per share over the last four quarters. What is Incyte's price-to-earnings ratio? Incyte (NASDAQ:INCY) has a trailing price-to-earnings ratio of 16.08 and a forward price-to-earnings ratio of 14.99. The price/earnings-to-growth ratio is 1.33. What is Incyte's EPS forecast for next year? Incyte's earnings are expected to grow from $3.54 per share to $4.49 per share in the next year, which is a 26.84% increase. More Earnings Resources from MarketBeat Related Companies: Charles River Laboratories International Earnings Medpace Earnings Exelixis Earnings National Research Earnings ICON Public Earnings IQVIA Earnings Bio-Techne Earnings Tenet Healthcare Earnings DaVita Earnings Shockwave Medical Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:INCY) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.